Chabot-Fletcher, M C et al
"Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.." Journal of Pharmacology and Experimental Therapeutics
273.3
(1995):
1147-1155.
Web. 16 April. 2024.